Literature DB >> 11754101

NPC1: Complete genomic sequence, mutation analysis, and characterization of haplotypes.

Peter Bauer1, Rupert Knoblich, Claudia Bauer, Ulrich Finckh, Antje Hufen, Julia Kropp, Silja Braun, Birgit Kustermann-Kuhn, Dörthe Schmidt, Klaus Harzer, Arndt Rolfs.   

Abstract

Niemann-Pick type C disease (NP-C) is a rare, autosomal recessive lipid storage disorder. At least 96% of all NP-C patients link to NPC1 which encodes for a lysosomally-targeted protein. We describe the complete genomic sequence of 57,052 kb corresponding to the transcribed region of human NPC1 including several exonic and intronic single nucleotide polymorphisms (SNPs). Sequencing of all exons, splice sites, and the promoter region of NPC1 in 12 unrelated Caucasian NP-C patients revealed nine novel and four known most likely disease-causing mutations. Ten unique mutations found only once in 24 disease alleles were observed in patients being compound heterozygous for two different mutations. Two of the three missense mutations identified more than once were observed in a total of four patients homozygous for the respective mutation along with homozygosity for the underlying haplotype. The patients were offspring of most likely nonconsanguineous couples. Based upon genotyping exonic SNPs c.2572A>G (I858V; g.45020A>G) and c.2793C>T (N931N; g.45686C>T) and segregation analysis we characterized the haplotype of all 24 NPC1 alleles and of 138 alleles of healthy Caucasian control subjects. All four permutations between the two SNPs were identified in the control alleles: 2572A-2793C (50%), 2572G-2793T (41%), 2572G-2793C (5%), and 2572A-2793T (4%). These data are suggestive for an ancestral intragenic recombination within a genomic fragment of <666 bp. While 17 of 24 NP-C alleles (71%) shared haplotype 2572G-2793T, this haplotype accounted for only 41% in the controls (p=0.007; 2-sided Fisher exact test) suggesting the possibility of an influence of the haplotypic background on expression of missense mutations in NPC1. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754101     DOI: 10.1002/humu.10016

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  High-content screen for modifiers of Niemann-Pick type C disease in patient cells.

Authors:  Emily K Pugach; McKenna Feltes; Randal J Kaufman; Daniel S Ory; Anne G Bang
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

2.  Identification of novel mutations in the NPC1 gene in German patients with Niemann-Pick C disease.

Authors:  W E Kaminski; H H Klünemann; B Ibach; C Aslanidis; H E Klein; G Schmitz
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

3.  A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene.

Authors:  Shicheng Guo; Shuai Jiang; Narendranath Epperla; Yanyun Ma; Mehdi Maadooliat; Zhan Ye; Brent Olson; Minghua Wang; Terrie Kitchner; Jeffrey Joyce; Peng An; Fudi Wang; Robert Strenn; Joseph J Mazza; Jennifer K Meece; Wenyu Wu; Li Jin; Judith A Smith; Jiucun Wang; Steven J Schrodi
Journal:  Blood       Date:  2019-02-27       Impact factor: 22.113

Review 4.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

5.  [Niemann-Pick disease type C--a neurometabolic disease through disturbed intracellular lipid transport].

Authors:  A J Grau; M Weisbrod; E Hund; K Harzer
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

6.  Niemann-Pick type C disease proteins: orphan transporters or membrane rheostats?

Authors:  Andrew B Munkacsi; Anthony F Porto; Stephen L Sturley
Journal:  Future Lipidol       Date:  2007-06

Review 7.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12

8.  The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes.

Authors:  William S Garver; David Jelinek; F John Meaney; James Flynn; Kathleen M Pettit; Glen Shepherd; Randall A Heidenreich; Cate M Walsh Vockley; Graciela Castro; Gordon A Francis
Journal:  J Lipid Res       Date:  2009-09-09       Impact factor: 5.922

9.  Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations.

Authors:  Tatiana Fancello; Andrea Dardis; Camillo Rosano; Patrizia Tarugi; Barbara Tappino; Stefania Zampieri; Elisa Pinotti; Fabio Corsolini; Simona Fecarotta; Adele D'Amico; Maja Di Rocco; Graziella Uziel; Sebastiano Calandra; Bruno Bembi; Mirella Filocamo
Journal:  Neurogenetics       Date:  2009-02-28       Impact factor: 2.660

10.  Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts.

Authors:  Dana L Cruz; Nina Pipalia; Shu Mao; Deepti Gadi; Gang Liu; Michael Grigalunas; Matthew O'Neill; Taylor R Quinn; Andi Kipper; Andreas Ekebergh; Alexander Dimmling; Carlos Gartner; Bruce J Melancon; Florence F Wagner; Edward Holson; Paul Helquist; Olaf Wiest; Frederick R Maxfield
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.